See how your Medicare performance compares with others in our
Stars Navigator Dashboard
Heart disease is the leading cause of death and disability in the US. Yet, thousands of patients with diabetes and cardiovascular disease remain under-treated, leaving them at risk for heart attacks, strokes, and costly hospitalizations.
For health plans and PBMs, these gaps in care not only harm members but also impact quality performance, leading to missed Star Rating goals and CMS incentives.
Our statin solutions close these critical gaps with advanced analytics and evidence-based outreach. The result? Healthier members, improved outcomes, and higher Star Ratings.
MAPD and PDP Contracts Supported
Star Ratings Achieved
Statin Gap Closure Rate across SUPD & SPC
Prescribers Cataloged with Response History and Preferred Communication Channels
We deliver end-to-end, scalable statin solutions that engage members, providers, and pharmacies to drive outcomes through evidence-based education.
Pharmacists deliver evidence-based education to help members understand the proven benefits of statin therapy and support shared decision-making.
Through data and direct engagement, we uncover what’s stopping members from starting or refilling therapy and guide them to overcome those barriers.
We engage members who decline statins with empathy and clear information - building trust and helping them make informed choices.
We reach out to members paying cash for statins to guide them in leveraging their plan benefits, ensuring measure compliance and sustained adherence.
We flag members who meet measure exclusions and work with providers to document these cases, ensuring accurate and compliant reporting.
Our solution drives 36% statin gap closure rates with an average of $1,805 in savings per member annually.
Let’s work together to close statin gaps, reduce cardiovascular risk, and elevate your Stars performance.
Contact us to get started.
Stay ahead with the latest news, insights, and innovations from MedWatchers, delivered straight to your inbox.
